Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
08 February 2007Website:
http://www.accuray.comNext earnings report:
31 January 2025Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 22 Nov 2024 22:51:55 GMTDividend
Analysts recommendations
Institutional Ownership
ARAY Latest News
ARAY's first-quarter fiscal 2025 earnings meet estimates. Both the top and bottom lines deteriorate year over year.
Accuray Incorporated (ARAY) Q1 2025 Earnings Call Transcript
MADISON, Wis., Oct. 23, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2025, ended September 30, 2024, during a conference call hosted by company management at 1:30 p.m.
MADISON, Wis. , Oct. 21, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Michael Murphy, CPA has joined the company as Vice President, Corporate Controller.
ARAY's solid product demand and revenue growth raise optimism about the stock.
Accuray is the first industry partner to open a facility at the Genolier Innovation Hub, created to provide opportunities for clinician-industry collaborations that can help accelerate improvements in patient care New Accuray CyberComm™ tool was used to significantly reduce the CyberKnife® S7™ System's commissioning time and enable product training in Genolier to begin more quickly MADISON, Wis. , Sept. 30, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the initiation of CyberKnife® S7™ System medical professional training at its education center located within the newly opened Genolier Innovation Hub, a fully-owned subsidiary of AEVIS VICTORIA SA, in Switzerland.
ARAY's solid product demand and revenue growth raise optimism about the stock.
The latest adoption of Accuray's Radixact System and VitalHold package is likely to improve the care provided to cancer patients and their experience.
MADISON, Wis. , Sept. 3, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that President and Chief Executive Officer Suzanne Winter will be taking a temporary medical leave of absence to receive care for a treatable form of cancer, effective immediately.
Developed for India and other countries where patient access to care with radiotherapy is challenged and where versatility and ease of use are a high priority Drives the next phase of company's strategic plan to expand its portfolio of helical radiation therapy delivery systems MADISON, Wis. , Aug. 27, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the company has received CE Mark for Accuray Helix™, a CT-guided helical radiotherapy system designed to provide high-performance and high-throughput.
What type of business is Accuray Incorporated?
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
What sector is Accuray Incorporated in?
Accuray Incorporated is in the Healthcare sector
What industry is Accuray Incorporated in?
Accuray Incorporated is in the Medical Devices industry
What country is Accuray Incorporated from?
Accuray Incorporated is headquartered in United States
When did Accuray Incorporated go public?
Accuray Incorporated initial public offering (IPO) was on 08 February 2007
What is Accuray Incorporated website?
https://www.accuray.com
Is Accuray Incorporated in the S&P 500?
No, Accuray Incorporated is not included in the S&P 500 index
Is Accuray Incorporated in the NASDAQ 100?
No, Accuray Incorporated is not included in the NASDAQ 100 index
Is Accuray Incorporated in the Dow Jones?
No, Accuray Incorporated is not included in the Dow Jones index
When was Accuray Incorporated the previous earnings report?
No data
When does Accuray Incorporated earnings report?
The next expected earnings date for Accuray Incorporated is 31 January 2025